The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin

Background: Whether metformin may reduce the risk of age-related macular degeneration (AMD) requires confirmation. This study compared the risk of AMD between ever users and never users of metformin matched on propensity score (PS) in Taiwanese patients with type 2 diabetes mellitus. Methods: We enr...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963185/
https://www.ncbi.nlm.nih.gov/pubmed/37259372
http://dx.doi.org/10.3390/ph16020224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963185/
https://www.ncbi.nlm.nih.gov/pubmed/37259372
http://dx.doi.org/10.3390/ph16020224

Ejemplares similares